Evidence map›Paper›PMID 39198549›Full record

ArticleNPJ precision oncology2024

Author Correction: TKI type switching overcomes ROS1 L2086F in ROS1 fusion-positive cancers.

Rajat Thawani, Matteo Repetto, Clare Keddy, Katelyn Nicholson, Kristen Jones, Kevin Nusser, Catherine Z Beach, Guilherme Harada, Alexander Drilon, Monika A Davare

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in NPJ precision oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Rajat Thawani *Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.ORCID http://orcid.org/0000-0002-5378-9434
Matteo Repetto *Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, 10065, USA.
Clare KeddyDepartment of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.
Katelyn NicholsonDepartment of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.
Kristen JonesDepartment of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.
Kevin NusserDepartment of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.
Catherine Z BeachDepartment of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.ORCID http://orcid.org/0000-0003-0750-3658
Guilherme HaradaThoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, 10065, USA.
Alexander DrilonThoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, 10065, USA. drilona@mskcc.org.ORCID http://orcid.org/0000-0001-6806-9061
Monika A DavareDepartment of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA. davarem@ohsu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39198549
PMCPMC11358392

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.